Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals. (Q33290485)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Juan Carlos Sepulveda-Arias

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Leonardo Beltrán

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Carlos Isaza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Julieta Henao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

José H Isaza Martínez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

11 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

BMC Clinical Pharmacology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.

1 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Pharmacogenomics of proton pump inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Pharmacogenetics of the proton pump inhibitors: a systematic review.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Mephenytoin hydroxylation in the Cuna Amerindians of Panama

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Identification and functional characterization of new potentially defective alleles of human CYP2C19.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

CYP2C19‐ and CYP3A4‐Dependent Omeprazole Metabolism in West Mexicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-7-6

SNaPshot for pharmacogenetics by minisequencing.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

The clinical role of cytochrome p450 genotypes in Helicobacter pylori management

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950696

A multifamily study on the relationship between CYP2C19 genotype and S-mephenytoin oxidation phenotype

31 October 2018

1 reference

12 December 2020

Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples

1 reference

12 December 2020

The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism

1 reference

12 December 2020

Frequencies of defective CYP2C19 alleles in a Hong Kong Chinese population: detection of the rare allele CYP2C19*4

1 reference

12 December 2020

Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world

1 reference

12 December 2020

Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood

1 reference

12 December 2020

Polymorphisms and the Pocketbook: The Cost‐Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of Helicobacter pylori Infection Associated with Duodenal Ulcer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6904-7-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 January 2020

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6904-7-6

9 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17623107%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

17623107

1 reference